Conclusions: Promoting biotechnology innovation in developing countries

Article Abstract:

Several factors that encourage successful development, and several common challenges that countries share in continuing and sustaining development of healthcare biotechnology are identified. The various lessons learned including ways to promote health biotechnology in developing countries such as political will, individual leadership, close linkages, enterprise creation, and intellectual property are highlighted.

---

Biotechnology and the UN's millennium development goals

Article Abstract:

The 189 member states of United Nations have committed to achieve the Millennium Development Goals (MDGs) by 2015. The MDGs are aimed at poverty reduction, improved education and health, and environmental sustainability and also, an attempt is made to compare directly biotechnology solutions with development goals.

Strategy & planning, Biological Product (except Diagnostic) Manufacturing, Molecular Biological Products, Methods, Planning, Development and progression, Surveys, Developmental biology, United Nations, Biotechnology, Company business planning, Economic recovery, 2015 AD

---

Introduction: Promoting global health through biotechnology

Article Abstract:

The importance of studying health biotechnology innovation systems in developing countries is addressed using case studies of seven countries. The lessons that can be applied in developing countries and, which can be useful for industrially advanced countries are highlighted.

Analysis

Similar abstracts:

• Abstracts: Competition among trading venues: information and trading on electronic communications networks. Liquidity externalities and adverse selection: evidence from trading after hours
• Abstracts: The number on biotech indexes. Putting biotech risk in its place. Going short on biotech
• Abstracts: Canada's bumper biotech budget. Angel investors shy away from biotech
• Abstracts: Politics torpedo biotech as EU priority. Taiwan: biotech vision. Germany biotech gets second chance
• Abstracts: Edmund D. Pellegrino. DNA vaccines-back in the saddle again?

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.